1. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013;31(Suppl 4):D7–12.
2. Sigler K, Spizek J, Rezanka T. Medicinal use of Lincosamides and microbial resistance to them. Anti-Infective Agents in Medicinal Chemistry (Formerly â Current Medicinal Chemistry - Anti-Infective Agents). 2007;6(2):133–44.
3. Hoeksema H, Bannister B, Birkenmeyer RD, Kagan F, Magerlein BJ, Mackellar FA, Schroeder W, Slomp G, Herr RR. Chemical studies on Lincomycin. I. the structure of Lincomycin. J Am Chem Soc. 1964;86(19):195–209.
4. Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H. Ampicillin + sulbactam vs. clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect. 2004;10(2):163–70.
5. Bartlett JG. Methicillin-resistant Staphylococcus aureus infections. Top HIV Med. 2008;16(5):151–5.